Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance
Portfolio Pulse from
Sabra Health Care REIT, Inc. reported its fourth quarter 2024 results, showing a net income of $0.19 per diluted share and an FFO of $0.36. The company also introduced its 2025 guidance.
February 19, 2025 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sabra Health Care REIT reported Q4 2024 earnings with net income of $0.19 per share and FFO of $0.36. The company also provided guidance for 2025.
The positive earnings report and introduction of 2025 guidance are likely to have a favorable impact on SBRA's stock price in the short term. The net income and FFO figures indicate solid financial performance, which is typically viewed positively by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100